化学药品吸入液体制剂药学研究技术要求(征求意见稿)

2021-07-02 国家药品监督管理局药品审评中心(CDE) CDE

为规范和指导化学药品吸入液体制剂的药学研究,我中心组织制订了《化学药品吸入液体制剂药学研究技术要求(征求意见稿)》。

中文标题:

化学药品吸入液体制剂药学研究技术要求(征求意见稿)

发布日期:

2021-07-02

简要介绍:

 为规范和指导化学药品吸入液体制剂的药学研究,我中心组织制订了《化学药品吸入液体制剂药学研究技术要求(征求意见稿)》。
       我们诚挚地欢迎社会各界对征求意见稿提出宝贵意见和建议,并及时反馈给我们,以便后续完善。征求意见时限为自发布之日起一个月。
       请将您的反馈意见发到以下联系人的邮箱:
       联系人:刘晓静,姚方耀
       联系方式:liuxiaojing@cde.org.cn
                         yaofy@cde.org.cn
       感谢您的参与和大力支持。
                                                                                                                           国家药品监督管理局药品审评中心
                                                                                                                                         2021年7月2日

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a8a361c00212554e, title=化学药品吸入液体制剂药学研究技术要求(征求意见稿), enTitle=, guiderFrom=CDE, authorId=0, author=, summary= 为规范和指导化学药品吸入液体制剂的药学研究,我中心组织制订了《化学药品吸入液体制剂药学研究技术要求(征求意见稿)》。, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Fri Jul 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">&nbsp;为规范和指导化学药品吸入液体制剂的药学研究,我中心组织制订了《化学药品吸入液体制剂药学研究技术要求(征求意见稿)》。</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 我们诚挚地欢迎社会各界对征求意见稿提出宝贵意见和建议,并及时反馈给我们,以便后续完善。征求意见时限为自发布之日起一个月。</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 请将您的反馈意见发到以下联系人的邮箱:</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 联系人:刘晓静,姚方耀</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 联系方式:liuxiaojing@cde.org.cn</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yaofy@cde.org.cn</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 感谢您的参与和大力支持。</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 国家药品监督管理局药品审评中心</span><br style="color: #333333;" /><span style="color: #333333;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2021年7月2日</span></p>, tagList=[TagDto(tagId=112, tagName=药学)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10431, appHits=26, showAppHits=0, pcHits=545, showPcHits=10405, likes=0, shares=6, comments=3, approvalStatus=1, publishedTime=Sun Jul 04 22:19:35 CST 2021, publishedTimeString=2021-07-02, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sun Jul 04 22:19:32 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 02:53:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=996810, encodeId=17f099681096, content=理学药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 14:04:49 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996708, encodeId=22b0996e08dd, content=理学主题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:20:43 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996333, encodeId=eb5b99633327, content=吸纳意见的东西扣那么积分干嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jul 05 09:35:14 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-06 ms3000001999514966

    理学药物

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=996810, encodeId=17f099681096, content=理学药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 14:04:49 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996708, encodeId=22b0996e08dd, content=理学主题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:20:43 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996333, encodeId=eb5b99633327, content=吸纳意见的东西扣那么积分干嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jul 05 09:35:14 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-06 ms3000001999514966

    理学主题

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=996810, encodeId=17f099681096, content=理学药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 14:04:49 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996708, encodeId=22b0996e08dd, content=理学主题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:20:43 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996333, encodeId=eb5b99633327, content=吸纳意见的东西扣那么积分干嘛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jul 05 09:35:14 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-05 微探

    吸纳意见的东西扣那么积分干嘛

    0